Cor Vasa 2016, 58(3):e303-e309 | DOI: 10.1016/j.crvasa.2015.09.001

Diagnostic value of electrocardiographic (resting and 24-h Holter) monitoring in comparison with NT-proBNP in the differential diagnosis of patients with cardiogenic and neurogenic syncope

Piotr J. Stryjewskia,*, Agnieszka Kuczajb, Ryszard Braczkowskic, Jadwiga Nesslerd, Ewa Nowalany-Kozielskab
a Cardiology Department, Chrzanow City Hospital, Poland
b 2nd Department of Cardiology, Zabrze, Medical University of Silesia, Katowice, Poland
c Department of Public Health, School of Public Health, Silesian Medical University, Poland
d Coronary Disease Department, Institute of Cardiology, Medical School of Jagiellonian University, John Paul II Hospital, Cracow, Poland

Background: Syncope is a cause of 1-6% of hospitalizations. Both European and American syncope guidelines recommend a 12-lead ECG as part of the evaluation of all patients with unexplained loss of consciousness.

Objectives: The aim of this study was the assessment of the significance of ECG, Holter ECG and the concentration of NT-proBNP that would be useful in the differentiation of patients with cardiac and reflex syncope.

Methods: We investigated 100 patients (56 men), aged 18-77 years with reflex or cardiac syncope over the last 3 years. The following factors were investigated: age, sex, systolic and diastolic blood pressure, the presence of cardiovascular disease. Moreover, we assessed basic resting ECG parameters and 24-hour Holter ECG parameters, and NT-proBNP concentration in the differential diagnosis of syncope.

Results: Patients with reflex syncope were younger compared to patients with cardiac syncope (44.4 ± 16.5 vs. 60.8 ± 12.6; p < 0.001). A pathologic resting 12-lead ECG was present more frequently in the group with a cardiogenic type of syncope - 12 (24%) vs. 8 (16%). 24-hour Holter ECG monitoring showed no statistically significant difference between minimal, mean and maximal heart rates in the analyzed groups. However, statistically significant differences were observed in the occurrence of ventricular and supraventricular arrhythmias between the investigated groups. Patients with cardiac syncope had significantly higher concentrations of NT-proBNP compared to patients with reflex syncope (448.7 ± 212.2 vs. 68.2 ± 64.1; p < 0.0001).

Conclusions: Elevated NT-proBNP concentration is present in patients with a cardiogenic mechanism of syncope, despite the fact that a resting ECG is inconclusive.

Keywords: 24-h Holter; Electrocardiography; NT-proBNP; Syncope

Received: April 3, 2015; Revised: August 26, 2015; Accepted: September 3, 2015; Published: June 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stryjewski PJ, Kuczaj A, Braczkowski R, Nessler J, Nowalany-Kozielska E. Diagnostic value of electrocardiographic (resting and 24-h Holter) monitoring in comparison with NT-proBNP in the differential diagnosis of patients with cardiogenic and neurogenic syncope. Cor Vasa. 2016;58(3):e303-309. doi: 10.1016/j.crvasa.2015.09.001.
Download citation

References

  1. A. Moya, R. Sutton, F. Ammirati, et al., Guidelines for the diagnosis and management of syncope (version 2009). The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC), European Heart Journal 30 (2009) 2631-2671. Go to original source... Go to PubMed...
  2. J.S. Huff, W.W. Decker, J.V. Quinn, et al., Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope, Annals of Emergency Medicine 49 (2007) 431-444. Go to original source... Go to PubMed...
  3. M.H. Ruwald, W. Zaremba, ECG monitoring in syncope, Progress in Cardiovascular Diseases 56 (2013) 203-210. Go to original source... Go to PubMed...
  4. V. Thiruganasambandamoorthy, E.P. Hess, A. Alreesi, et al., External validation of the San Francisco syncope rule in the Canadian setting, Annals of Emergency Medicine 55 (2010) 464-472. Go to original source... Go to PubMed...
  5. M.T. Rademaker, A.M. Richards, Cardiac natriuretic peptides for cardiac health, Clinical Science (London) 108 (2005) 23-36. Go to original source... Go to PubMed...
  6. P.J. Stryjewski, B. Nessler, A. Kuczaj, et al., The role of NT-proBNP in the diagnostics and differentiation of cardiac and reflex syncope in adults. Relative importance to clinical presentation and medical examinations, Journal of Interventional Cardiac Electrophysiology 41 (2014) 1-8. Go to original source... Go to PubMed...
  7. R. Pfister, J. Hagemeister, S. Esser, et al., NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope, International Journal of Cardiology 155 (2012) 268-272. Go to original source... Go to PubMed...
  8. K. Tanimoto, K. Yukiiri, K. Mizushige, et al., Usefulness of brain natriuretic peptide as a marker for separating cardiac and noncardiac causes of syncope, American Journal of Cardiology 93 (2004) 228-230. Go to original source... Go to PubMed...
  9. A.P. Fitzpatrick, G. Theodorakis, P. Vardas, et al., Methodology of head-up tilt testing in patient with unexplained syncope, Journal of the American College of Cardiology 17 (1991) 125-130. Go to original source... Go to PubMed...
  10. T.C. Gibson, M.R. Heitzman, Diagnostic efficacy of 24 hour electrocardiographic monitoring for syncope, American Journal of Cardiology 53 (1984) 1013-1017. Go to original source... Go to PubMed...
  11. A.D. Krahn, G.J. Klein, R. Yee, et al., Use of an extended monitoring strategy in patients with problematic syncope, Circulation 99 (1999) 406-410. Go to original source...
  12. M. Brignole, L. Gianfranchi, C. Menozzi, et al., Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation, Journal of the American College of Cardiology 22 (1993) 1123-1129. Go to original source... Go to PubMed...
  13. S. Inoue, Y. Murakami, K. Sano, et al., Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation, Journal of Cardiac Failure 6 (2000) 92-96. Go to original source... Go to PubMed...
  14. J.W. Leitch, G.J. Klein, R. Yee, et al., Syncope associated with supraventricular tachycardia: an expression of tachycardia or vasomotor response?, Circulation 85 (1992) 1064-1071. Go to original source... Go to PubMed...
  15. B. Olshansky, J.E. Poole, G. Johnson, et al., Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study, Journal of the American College of Cardiology 51 (2008) 1277-1282. Go to original source... Go to PubMed...
  16. R.M. John, U.B. Tedrow, B.A. Koplan, et al., Ventricular arrhythmias and sudden cardiac death, Lancet 380 (2012) 1520-1529. Go to original source... Go to PubMed...
  17. G. Klein, C. Lissel, A.C. Fuchs, et al., Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT Study, Europace 8 (2006) 618-624. Go to original source... Go to PubMed...
  18. P.J. Stryjewski, B. Nessler, M. Paweł, et al., Natriuretic peptides and their use in clinical practice according to the guidelines of the European Society of Cardiology, Przeglad Lekarski 71 (2014) 33-35. Go to PubMed...
  19. E.G. Manios, E.M. Kallergis, E.M. Kanoupakis, et al., Amino-terminal pro-brain natriuretic peptide predicts ventricular arrhythmogenesis in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillators, Chest 128 (2005) 2604-2610. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.